The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...
Among postmenopausal women, hormone therapy (HT) use is associated with an increased incidence and risk for developing autoimmune disease.
The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, ...
Postmenopausal women using hormone therapy were more likely to develop autoimmune diseases compared with nonusers, research ...
MedPage Today on MSN
Hormone Therapy Linked to Autoimmune Disease in Women
Indeed, risk factors for autoimmune diseases in postmenopausal women include dysbiosis, low vitamin D, and immune aging; ...
The Polycystic Ovary Syndrome community is growing online. But how do the symptoms affect Black women specifically? Experts weigh in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback